Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 1, 2021
- Accepted in final form September 14, 2021
- First Published November 10, 2021.
Author Disclosures
- Gemma Olivé-Cirera, MD (olive.cirera.gemma{at}gmail.com),
- Elianet Fonseca, MD (elianet.fonsec{at}gmail.com),
- Verónica Cantarín-Extremera, MD (veronica.cantarin{at}salud.madrid.org),
- María Vázquez-López, MD (maria.vazquez{at}salud.madrid.org),
- María Jiménez-Legido, MD (mjimenezl{at}salud.madrid.org),
- Verónica González-Álvarez, MD (vgonzalez{at}sjdhospitalbarcelona.org),
- Juliana Ribeiro-Constante, MD (jribeiroconstante{at}gmail.com),
- Ana Camacho-Salas, MD (acamachosalas{at}yahoo.es),
- Itxaso Martí, MD (itxasomarti{at}gmail.com),
- Ramon Cancho-Candela, MD (rcanchoc{at}saludcastillayleon.es),
- María Jesús Martínez-González, MD (mariajesus.martinezgonzalez{at}osakidetza.eus),
- Albert Saiz, MD, PhD (asaiz{at}clinic.cat) and
- Thaís Armangué, MD, PhD
- on behalf of the Spanish Study Group NeuroimmunoPed-Covid
- Gemma Olivé-Cirera, MD (olive.cirera.gemma{at}gmail.com),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
INVEST-AEP fellowship 2019 of the Pediatric Spanish Society
NONE
NONE
NONE
NONE
NONE
NONE
- Elianet Fonseca, MD (elianet.fonsec{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Verónica Cantarín-Extremera, MD (veronica.cantarin{at}salud.madrid.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- María Vázquez-López, MD (maria.vazquez{at}salud.madrid.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- María Jiménez-Legido, MD (mjimenezl{at}salud.madrid.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Verónica González-Álvarez, MD (vgonzalez{at}sjdhospitalbarcelona.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Juliana Ribeiro-Constante, MD (jribeiroconstante{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ana Camacho-Salas, MD (acamachosalas{at}yahoo.es),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Itxaso Martí, MD (itxasomarti{at}gmail.com),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Basque regional goverment from Spain. Grant : 20BU211: Creation of a virtual reality program for the EEG. 15000 Euros. 2020-2022. Principal investigator.
Basque University( UPV/ EHU). GIU20/057, Grant of 38.720 Euros as a grant for research teams in the university. Neuroscience group. I do not receive direct compensation from this grant
None
NONE
NONE
NONE
NONE
NONE
NONE
- Ramon Cancho-Candela, MD (rcanchoc{at}saludcastillayleon.es),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- María Jesús Martínez-González, MD (mariajesus.martinezgonzalez{at}osakidetza.eus),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Albert Saiz, MD, PhD (asaiz{at}clinic.cat) and
NONE
NONE
compensation for consulting services and speaker honoraria from Bayer-Schering, Merck-Serono, Biogen-Idec, Sanofi-Aventis, Teva Pharmaceutical Industries Ltd, Novartis, Alexion,and Roche
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thaís Armangué, MD, PhD
None
NONE
I received speaker honnoraria from Novartis, Biogen and Sanofi-Aventis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I received research support from Instituto Carlos III (PI18/00486 and PI21/00316), and Govern de la Generalitat de Catalunya (SLT006/17/00362)
NONE
I received research support from Mutua Madrilena Fundation AP162572016 and La Marato de TV3 foundation (37/C/2021), Torrons Vicens Foundation grant (PFNR0144), Pablove Foundation (pC ID): 689368), and 2021 Invest AEP Grant
NONE
NONE
NONE
NONE
NONE
NONE
- From the Pediatric Neuroimmunology Program (G.O.-C.,E.F.,A.S.,T.A.), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Hospital Clinic, University of Barcelona; Pediatric Neurology Unit of Parc Taulí Hospital of Sabadell (G.O.-C.), Barcelona; Pediatric Neurology Unit of Hospital Infantil Universitario Niño Jesús (V.C.-E.,M.J.-L.), Madrid; Pediatric Neurology Unit of Hospital Gregorio Marañón (M.V.-L.), Madrid; Pediatric Neuroimmunology Unit (V.G.-A.,J.R.-C.,T.A.), Neurology Service, Sant Joan de Déu (SJD) Children's Hospital, University of Barcelona; Pediatric Neurology Unit of Hospital Universitario 12 de Octubre, Complutense University of Madrid (A.C.S.); Pediatric Neurology Unit of Hospital Universitario Donostia (I.M.), Guipuzcoa; Pediatric Neurology Unit of Hospital Universitario Río Hortega (R.C.-C.), Valladolid; and Pediatric Neurology Unit of Cruces University Hospital (M.J.M.-G.), Bilbao, Spain.
- Correspondence
Dr. Armangué armangue{at}clinic.cat
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.